Longevity Peptides: A Research Overview of Epitalon, Klotho, NAD+, and Mitochondrial Peptides

Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.

Introduction

The biology of aging — once a peripheral subject in mainstream pharmacology — has become one of the most active areas in contemporary preclinical research. Within this expanding field, a structurally and mechanistically diverse class of compounds has emerged under the umbrella term longevity peptides. Longevity peptides research spans short synthetic tetrapeptides like Epitalon, longevity-associated proteins like Klotho, the broader NAD+-centered metabolic-aging research program, and the mitochondrial-derived peptides that have reframed understanding of mitochondrial-nuclear communication.

These compounds do not share a common molecular target. Instead, they are grouped by their experimental application: all are studied in preclinical models examining hallmarks of aging — telomere attrition, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, and altered intercellular communication. This article outlines the principal members of the longevity peptide research class, their underlying biology, and the experimental contexts in which each is most commonly studied.

Peptide Class Overview

The longevity peptides research class is unified by experimental framing rather than chemistry. Epitalon (Ala-Glu-Asp-Gly) is a short synthetic tetrapeptide derived from the pineal extract Epithalamin. Klotho is a single-pass transmembrane protein with secreted and intracellular forms — too large to chemically synthesize as a research peptide, but studied at the protein and gene level alongside klotho-derived research peptide fragments. NAD+ is not a peptide but a pyridine nucleotide coenzyme; nevertheless, NAD+-centered research connects intimately to peptide-based longevity biology through its role as a sirtuin cofactor and through the use of small-molecule precursors such as NMN and NR. The mitochondrial-derived peptides — MOTS-c, humanin, and the SHLPs — form a structurally distinct but functionally relevant group within the longevity peptide research landscape. FOXO4-DRI, a retro-inverso D-amino acid senolytic peptide, has emerged as a distinct research tool for cellular senescence biology. And the broader Khavinson peptide bioregulator class — including Pinealon, Vesugen, and related tripeptides — contributes additional exploratory tools.

The research framing of this class is centered on the canonical “hallmarks of aging” — genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Each major compound in the longevity peptide class addresses one or more of these hallmarks, making the conceptual framework a useful organizing scheme for understanding research applications. The class as a whole bridges molecular gerontology with peptide pharmacology and is one of the most rapidly growing areas of contemporary preclinical aging research.

Historically, the longevity peptide field traces several distinct lineages. The Khavinson school in St. Petersburg developed Epitalon, Pinealon, and related short bioregulator peptides through extracts of organ tissues, hypothesizing direct epigenetic actions. The mitochondrial-derived peptide lineage originated with the 2003 discovery of humanin by Hashimoto and colleagues in the context of Alzheimer’s disease research, with subsequent characterization of MOTS-c (Lee et al., 2015) and the SHLP family (Cobb et al., 2016) extending the conceptual framework. The klotho biology lineage originated with Kuro-o et al.’s 1997 identification of the accelerated-aging klotho mutant mouse. NAD+ aging research has the longest history, building on decades of sirtuin research that culminated in the modern translational interest in NAD+ precursor supplementation. These distinct historical lineages have converged into the modern longevity peptide research framework.

Shared Mechanisms and Research Context

While each compound in this class has a distinct primary mechanism, several themes recur across the literature. These include: regulation of telomere maintenance and telomerase activity; modulation of mitochondrial bioenergetics; influence on AMPK and sirtuin signaling pathways; effects on inflammatory and oxidative stress markers; and alteration of senescence-associated phenotypes in cellular models. Common research designs use aged rodent cohorts, accelerated-aging genetic models (such as klotho-deficient mice), high-fat-diet metabolic stress models, and replicatively aged cell culture systems.

The framework of “hallmarks of aging” published by López-Otín and colleagues in 2013 has become the dominant conceptual scaffold for organizing longevity peptide research. Across the original nine hallmarks (genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication), most longevity peptide research engages two or more hallmarks simultaneously. For example, MOTS-c addresses mitochondrial dysfunction, deregulated nutrient sensing, and altered intercellular communication; NAD+ precursors engage mitochondrial dysfunction, deregulated nutrient sensing, and epigenetic alterations through sirtuin-dependent histone deacetylation.

The research community has also developed standard biomarker panels for aged-cohort studies, including biological age estimators (DNA methylation clocks such as the Horvath, Hannum, and PhenoAge clocks), inflammatory markers (IL-6, TNF-α, CRP), cellular senescence indicators (p16INK4a, SA-β-galactosidase staining), and metabolic parameters (insulin sensitivity, glucose tolerance, mitochondrial respiration). These panels provide quantitative endpoints that complement traditional lifespan and healthspan measurements.

Key Research Areas

1. Epitalon — Telomerase Modulation Research

Epitalon (also spelled epithalon; sequence Ala-Glu-Asp-Gly) is a tetrapeptide originally isolated from pineal gland extract Epithalamin and characterized by Vladimir Khavinson’s research group at the St. Petersburg Institute of Bioregulation and Gerontology. The peptide has been studied extensively in cellular aging models. Khavinson, Bondarev, and Butyugov (2003) reported that Epitalon induces telomerase activity and telomere elongation in human somatic cells in culture [1]. Subsequent work by Khavinson and colleagues (2020) documented Epitalon’s effects on gene expression during neurogenesis and suggested potential epigenetic mechanisms involving direct peptide-DNA interactions [2]. Anisimov et al. (2003) reported that long-term administration of Epitalon to female mice slowed age-related changes in estrous function and the development of spontaneous tumors in an aged cohort study [9]. Research applications include cellular senescence assays, telomere length measurement experiments, and aged rodent cohort studies.

2. Klotho — Longevity Protein Biology

Klotho was discovered in 1997 when Kuro-o and colleagues identified a mouse mutant exhibiting accelerated aging traits including stunted growth, osteopenia, vascular calcification, and short lifespan [3]. The mutated gene was named “klotho” after the Greek goddess who spins the thread of life. Subsequent work demonstrated that klotho overexpression extends lifespan in mice [4]. The klotho protein has three functional forms: membrane-bound (which acts as a co-receptor for FGF23), secreted (which circulates and exerts pleiotropic effects on oxidative stress and ion homeostasis), and intracellular. While the full klotho protein is too large for chemical synthesis as a research peptide, klotho-derived peptide fragments and recombinant secreted klotho are used in preclinical studies. Dubal et al. (2014) reported that elevated klotho enhances cognition in mice and that a klotho variant is associated with improved cognition in humans, broadening the role of klotho beyond renal and metabolic biology into cognitive aging research [10]. The Klotho research literature now spans kidney disease models, neurodegeneration research, and aging biology more broadly.

3. NAD+ and the Sirtuin-Aging Axis

The decline of intracellular NAD+ with age — and its restoration through precursor supplementation — has become a foundational area of longevity research. NAD+ serves as the obligate cofactor for the seven mammalian sirtuins (SIRT1–7), a family of NAD+-dependent deacylases involved in metabolic regulation, mitochondrial biogenesis, and stress resistance. Bonkowski and Sinclair (2016) reviewed the rise of NAD+ and sirtuin-activating compounds in aging research [5]. Mills et al. (2016) demonstrated that long-term administration of the NAD+ precursor NMN mitigates age-associated physiological decline in mice [6]. Yoshino et al. (2018) reviewed NAD+ intermediates as therapeutic targets for aging biology and metabolic disease research, summarizing the multiple converging precursor pathways (NMN, NR, nicotinic acid) and their relative tissue distributions [11]. Research-grade NAD+ is supplied for use in preclinical metabolic research, cellular signaling studies, and aging biology experiments examining sirtuin activity, mitochondrial function, and metabolic homeostasis.

4. Mitochondrial-Derived Peptides in Aging Research

The mitochondrial-derived peptides (MDPs) class — humanin, MOTS-c, and SHLP1–6 — has emerged as a major contributor to the longevity peptide research literature since 2003. MOTS-c, in particular, has been characterized as an exercise-induced regulator of age-dependent physical decline and skeletal muscle homeostasis [7]. Cobb et al. (2016) demonstrated that levels of mitochondrial-derived peptides decline with age and that exogenous administration of these peptides modulates apoptosis, insulin sensitivity, and inflammatory markers in aged mice [8]. Lee et al. (2015) characterized MOTS-c as a regulator of insulin sensitivity and metabolic homeostasis, showing that exogenous MOTS-c improved insulin sensitivity and protected against diet-induced obesity in mice [12]. The MDPs occupy a unique position in longevity research because they bridge mitochondrial biology, metabolic regulation, and intercellular communication — three of the canonical hallmarks of aging. Research-grade MOTS-c is supplied for studies in this domain.

5. FOXO4-DRI — Senolytic Peptide Research

FOXO4-DRI is a retro-inverso D-amino acid peptide derived from the FOXO4 protein, designed to interfere with the FOXO4–p53 protein-protein interaction that allows senescent cells to evade apoptosis. Baar et al. (2017) reported that targeted apoptosis of senescent cells with FOXO4-DRI restored fitness, fur density, and renal function in aged and progeroid mice — establishing FOXO4-DRI as one of the most studied peptide-based senolytics in the cellular senescence research literature [13]. The peptide has become a widely used preclinical tool in studies of senescence-associated secretory phenotype (SASP) modulation, p53-mediated senescent cell clearance, and longevity-relevant tissue rejuvenation paradigms.

6. Humanin and the SHLP Family

Humanin is a 24-amino-acid peptide encoded by a small open reading frame within the mitochondrial 16S rRNA gene, first identified in 2001 by Hashimoto and colleagues for its capacity to protect neurons from amyloid-β–induced cytotoxicity. Beyond its original neuroprotective characterization, humanin has been studied as a regulator of insulin sensitivity, apoptosis, and inflammatory signaling. The small humanin-like peptides (SHLP1 through SHLP6) were subsequently identified by Cohen and colleagues as additional small ORFs within the same mitochondrial DNA region, each with distinct tissue distributions and biological activities. Cobb et al. (2016) reported that circulating SHLP2 levels decline with age in mice and humans, and that exogenous SHLP2 modulates insulin sensitivity and cardioprotective endpoints [8]. The humanin and SHLP family together represent one of the most active areas of mitochondrial-nuclear retrograde signaling research.

7. Pinealon and Khavinson Tripeptide Bioregulators

The Khavinson school of peptide bioregulator research has produced multiple short tripeptides studied as longevity-relevant compounds in addition to Epitalon. Pinealon (Glu-Asp-Arg) has been studied for neuroprotective and stress-response effects in cellular and rodent models. Vesugen (Lys-Glu-Asp) and Chonluten (Glu-Asp-Gly) are additional members of this class characterized for tissue-specific gene expression effects. The hypothesized mechanism involves direct interaction of the tripeptides with chromatin and transcription factor binding sites, though receptor-level confirmation remains incomplete. These tripeptides are useful primarily as exploratory research tools in epigenetic-aging paradigms.

Cross-Compound Mapping to Hallmarks of Aging

One of the most useful conceptual exercises in longevity peptide research is mapping each compound to the canonical hallmarks of aging it most directly engages. The following table summarizes the principal hallmark associations for each major compound in this research class:

This mapping clarifies why combination studies in longevity peptide research are scientifically attractive: pairing compounds that engage different hallmarks can address aging from multiple mechanistic angles simultaneously. For example, pairing MOTS-c (mitochondrial dysfunction) with FOXO4-DRI (cellular senescence) in an aged-mouse cohort study addresses two of the canonical hallmarks in a single experimental design. Combinations of NAD+ precursors with mitochondrial-derived peptides have similarly attracted research attention.

Experimental Design Considerations Specific to Longevity Peptide Research

Aged-cohort longevity research presents methodological challenges that are distinct from acute pharmacology studies. The following considerations apply across the longevity peptide research class:

Cohort selection and stratification. Aged animal cohorts exhibit substantial baseline heterogeneity in frailty, body weight, and metabolic parameters. Stratifying animals at study entry by baseline metrics — body weight, grip strength, or fasting glucose — reduces variance and improves the interpretability of treatment effects. For long-duration studies, baseline mortality must be factored into sample size calculations.

Outcome timing and longitudinal sampling. Many longevity-relevant endpoints (insulin sensitivity, frailty markers, gait parameters, body composition) are best measured longitudinally with repeated assessments rather than terminal endpoints alone. Pre-specified time points across the study window provide a richer dataset and enable trajectory analysis. Terminal endpoints (lifespan, histopathology, tissue gene expression) complement the longitudinal data.

Control group choice. Vehicle controls should be matched on all aspects except active peptide content, including reconstitution solvent, route of administration, and handling. For aged cohorts in particular, the stress of repeated injections itself can influence outcomes, so handling-only sham controls may be appropriate in some designs.

Biomarker selection. Modern longevity research routinely uses multi-omics panels — transcriptomics, proteomics, metabolomics — alongside traditional biomarker panels. DNA methylation aging clocks (Horvath, GrimAge, PhenoAge) are increasingly used as integrative readouts. Researchers planning longevity peptide studies should consider banking samples for retrospective multi-omics analysis even when these endpoints are not the primary focus.

Cross-species translation. Aging biology in mice differs from aging biology in humans in important ways, including the relative contribution of different hallmarks to age-related decline, the kinetics of aging-related changes, and the response to interventions. Mouse data should be interpreted with appropriate caution about translational extrapolation, and complementary work in non-mouse model systems (Caenorhabditis elegans, Drosophila, naked mole rat, killifish) can strengthen mechanistic conclusions.

Selection Criteria for Researchers

Choice of longevity peptide depends substantially on which hallmark of aging the experimental design addresses. The following selection criteria provide practical guidance:

• For telomere-focused research: Epitalon is the most-studied peptide tool, with published evidence of telomerase induction in cultured cells. Aged-cohort studies of Epitalon administration also exist in the rodent literature.
• For mitochondrial bioenergetics and metabolic aging: MOTS-c, NAD+ and its precursors, and humanin/SHLP family members all engage this domain. MOTS-c is particularly useful for studies of skeletal muscle metabolism and exercise biology. NAD+ precursors (NMN, NR) are useful for sirtuin-pathway research.
• For senescent-cell clearance and SASP research: FOXO4-DRI is the most-studied peptide-based senolytic, with well-characterized aged-mouse models and renal-function endpoints.
• For neuroprotection in aging: Humanin has the deepest neuroprotection literature in this class, with extensive characterization in amyloid-β cytotoxicity models. Klotho-pathway research peptides also contribute, given the established cognitive role of klotho.
• For pleiotropic anti-aging biology: Klotho-related peptides and the broader peptide bioregulator class have been studied for multi-tissue effects, though mechanistic understanding remains less mature than for the targeted compounds above.

Across the class, researchers should match the half-life and molecular size of the chosen peptide to the experimental timeframe. Short tetrapeptides like Epitalon have brief plasma half-lives but documented behavioral and gene-expression effects, while larger and more stable peptides (MOTS-c, humanin) enable longer-duration experimental designs.

Research Considerations for Laboratory Use

Longevity peptides comprise a chemically heterogeneous class with correspondingly varied handling requirements. Short synthetic peptides such as Epitalon are typically supplied lyophilized at ≥98% HPLC purity, stored at −20°C for long-term archiving, and reconstituted in bacteriostatic water for short-term experimental use. NAD+ and its precursors are sensitive to moisture and degradation; storage protocols typically specify desiccated conditions and minimal light exposure. Klotho-related research is most commonly conducted at the protein level using recombinant material, requiring cold-chain handling and protein-grade buffer systems. All material used in longevity research should be accompanied by Certificates of Analysis and characterized for purity and identity before initiating extended studies.

Aged-cohort study design carries specific methodological considerations beyond peptide handling. Sample-size calculations must account for higher baseline mortality in aged animals, and cohorts should include sufficient numbers to maintain statistical power through the experimental window. Cohort stratification at study entry — by body weight, baseline frailty markers, or genetic background — reduces variability and improves the interpretability of treatment effects. For combination studies pairing longevity peptides with caloric restriction, exercise, or other longevity interventions, factorial designs are appropriate but require substantially larger sample sizes than single-intervention studies.

For mitochondrial-derived peptide research specifically, attention should be paid to the source of the peptide and its sequence verification, since multiple isoforms and species variants exist (e.g., MOTS-c sequences from human vs. mouse mitochondrial genomes differ slightly). Mass spectrometry confirmation of the exact sequence is appropriate for any new research lot.

Conclusion

The longevity peptides research class brings together compounds of widely different chemistry — short synthetic tetrapeptides, complex transmembrane proteins, a pyridine nucleotide coenzyme, mitochondrial-encoded peptides, retro-inverso senolytic peptides, and bioregulator tripeptides — under a unified research framework: the investigation of biological aging. Epitalon offers a window into telomere and gene-expression aspects of aging biology. Klotho provides a longevity-relevant signaling protein with a robust loss-of-function genetic model. NAD+ research, anchored in the sirtuin biology literature, has opened metabolic dimensions of aging. The mitochondrial-derived peptides (MOTS-c, humanin, SHLPs) have introduced an entirely new conceptual layer — mitochondrial-nuclear retrograde signaling — to the aging field. FOXO4-DRI has provided the first peptide-based senolytic tool with reproducible aged-cohort data.

As preclinical aging research continues to evolve, longevity peptides will likely be examined increasingly in combination — paired in study designs that probe multiple aging hallmarks simultaneously. The convergence of peptide pharmacology, hallmarks-of-aging conceptual framework, and modern molecular biomarker panels (DNA methylation clocks, transcriptomic aging signatures, mitochondrial function assays) is positioning this research class for substantial methodological maturation in the coming decade. All work in this domain remains firmly preclinical, with broad mechanistic questions still actively under investigation.

References

1. Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590–592. PMID: 12937682.

1. Khavinson V, Linkova N, Dyatlova A, et al. AEDG Peptide (Epitalon) stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism. Molecules. 2020;25(3):609. PMID: 32019204.

1. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51. PMID: 9363890.

1. Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309(5742):1829–1833. PMID: 16123266.

1. Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17(11):679–690. PMID: 27552971.

1. Mills KF, Yoshida S, Stein LR, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24(6):795–806. PMID: 28068222.

1. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PMID: 33473109.

1. Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016;8(4):796–809. PMID: 27070352.

1. Anisimov VN, Khavinson VKh, Provinciali M, et al. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer. 2002;101(1):7-10. PMID: 12209581.

1. Dubal DB, Yokoyama JS, Zhu L, et al. Life extension factor klotho enhances cognition. Cell Rep. 2014;7(4):1065-1076. PMID: 24813892.

1. Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528. PMID: 29249689.

1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459.

1. Baar MP, Brandt RMC, Putavet DA, et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell. 2017;169(1):132-147.e16. PMID: 28340339.